ArticleCurrent oncology (Toronto, Ont.)2021

Phase Ib Study of Atezolizumab Plus Interferon-α with or without Bevacizumab in Patients with Metastatic Renal Cell Carcinoma and Other Solid Tumors.

Christian U Blank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.